首页> 美国卫生研究院文献>Oncotarget >Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway
【2h】

Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway

机译:lncRNA CASC2的下调通过激活Wnt /β-catenin信号通路促进膀胱癌细胞的增殖和转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Long noncoding RNAs cancer susceptibility candidate 2 (CASC2) have been demonstrated as playing crucial regulatory roles in a few of cancers. However, the biological function of lncRNA CASC2 in bladder cancer are still unclear. In this study, we found that lncRNA CASC2 was significantly down-regulated in bladder cancer tissues and cell lines by quantitative real time-PCR and associated with advanced TNM stage (III/IV). Moreover, overexpression of lncRNA CASC2 remarkably reduced the cell growth, migration and invasion, as well as promoted early apoptosis of bladder cancer cell in vitro. Furthermore, we illustrated that lncRNA CASC2 inhibited Wnt/β-catenin signal pathway activity by decrasing the β-catenin expression and reversing the downstream target gene expression of Wnt signaling pathway. Taken together, lncRNA CASC2 plays an pivotal role in bladder tumorigenesis and progression and may act as a potential biomarker for the treatment of bladder cancer.
机译:长的非编码RNA癌症易感候选物2(CASC2)已被证明在某些癌症中起着至关重要的调节作用。然而,lncRNA CASC2在膀胱癌中的生物学功能仍不清楚。在这项研究中,我们发现通过实时定量PCR,膀胱癌组织和细胞系中的lncRNA CASC2显着下调,并且与晚期TNM分期(III / IV)有关。此外,lncRNA CASC2的过表达显着降低了细胞的生长,迁移和侵袭,并促进了体外膀胱癌细胞的早期凋亡。此外,我们阐明了lncRNA CASC2通过裂解β-catenin表达并逆转Wnt信号通路的下游靶基因表达来抑制Wnt /β-catenin信号通路的活性。综上所述,lncRNA CASC2在膀胱肿瘤的发生和发展中起着举足轻重的作用,并可能作为治疗膀胱癌的潜在生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号